ImmunityBio Inc. Common Stock vs Lloyds Banking Group Plc American Depositary Shares — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while Lloyds Banking Group Plc American Depositary Shares trades at $5.39 (market cap $77.94B). The key difference: Lloyds Banking Group Plc American Depositary Shares is far larger — about 7.5× ImmunityBio Inc. Common Stock's market cap, and Lloyds Banking Group Plc American Depositary Shares pays a 4.04% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Lloyds Banking Group Plc American Depositary Shares for 0 Days on average.
| IBRX | LYG | |
|---|---|---|
Market Cap | $10.33B | $77.94B |
Volume | 11,745,198 | 14,129,607 |
Sector | Health | Financials |
52-Week High | $11.55 | $6.28 |
52-Week Low | $1.98 | $4.42 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.79B | $98.94B |
Dividend Yield | — | 4.04% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Lloyds Banking Group provides retail, commercial, and insurance services in the United Kingdom. Its banking brands include Lloyds Bank, Halifax, and Bank of Scotland.
Read more on LYG →